Market closedNon-fractional

Day One Biopharmaceuticals/DAWN

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Day One Biopharmaceuticals

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.

Ticker

DAWN

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Brisbane, United States

Employees

174

DAWN Metrics

BasicAdvanced
$1.2B
Market cap
-
P/E ratio
-$2.50
EPS
-1.45
Beta
-
Dividend rate
$1.2B
-1.45
10.926
10.655
0.101
-42.67%
-69.97%
3.98
3.98
-6.46
9.94%
-33.25%

What the Analysts think about DAWN

Analyst Ratings

Majority rating from 11 analysts.
Buy

DAWN Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$62M
14.50%
Profit margin
0.00%
NaN%

DAWN Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 8.54%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.61
-$0.54
-$0.64
-$0.72
-
Expected
-$0.61
-$0.60
-$0.58
-$0.66
-$0.62
Surprise
-0.02%
-10.35%
9.71%
8.54%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Day One Biopharmaceuticals stock?

Day One Biopharmaceuticals (DAWN) has a market cap of $1.2B as of July 05, 2024.

What is the P/E ratio for Day One Biopharmaceuticals stock?

The price to earnings (P/E) ratio for Day One Biopharmaceuticals (DAWN) stock is 0 as of July 05, 2024.

Does Day One Biopharmaceuticals stock pay dividends?

No, Day One Biopharmaceuticals (DAWN) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Day One Biopharmaceuticals dividend payment date?

Day One Biopharmaceuticals (DAWN) stock does not pay dividends to its shareholders.

What is the beta indicator for Day One Biopharmaceuticals?

Day One Biopharmaceuticals (DAWN) has a beta rating of -1.45. This means that it has an inverse relation to market volatility.

Buy or sell Day One Biopharmaceuticals stock

Buy or sell Day One Biopharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing